Skip to content

Stroke Mobility and Caregiver Outcomes

The Effect of Mobility Level in Stroke Patients on Anxiety, Depression, and Caregiver Burden in Caregivers

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07504848
Enrollment
64
Registered
2026-04-01
Start date
2026-04-02
Completion date
2026-04-15
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver, Stroke

Brief summary

This study was designed to determine the effect of functional mobility levels of stroke patients on caregiver burden, anxiety, and depression in their caregivers.

Interventions

None listed

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Stroke Patients: * Diagnosed with stroke according to WHO criteria (≥20% disability rate documented in Adult Disability Health Board Report) * Having a family member or relative who provides care * First-ever and unilateral stroke * Willing to participate voluntarily * Aged between 18-75 years * Post-stroke duration longer than 3 months * Stable vital signs * Scoring ≥24 on the Standardized Mini-Mental State Examination (SMMT) or the -Modified Mini-Mental State Examination for Illiterate Individuals (MMSE-E) * Able to understand and speak Turkish 2. Caregivers of Stroke Patients: * Willing to participate in the study * Living with the patient for at least 1 year * Being the primary (main responsible) caregiver and not receiving paid professional caregiving services * Aged 18 years or older * Scoring ≥24 on the Standardized Mini-Mental State Examination (SMMT) or MMSE-E

Exclusion criteria

1. Stroke Patients: * Presence of severe comorbid conditions * Unwillingness to participate * History of multiple strokes * Bilateral hemiplegia * Presence of major neurological, orthopedic, or rheumatologic disorders affecting the musculoskeletal system other than stroke * Congenital anomalies or amputation causing disability * Uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions * Botulinum toxin injection within the last 6 months * Inability to establish cooperation * Presence of neglect, aphasia, or hemianopsia 2. Caregivers of Stroke Patients: * Unwillingness to participate * Living with the patient for less than 1 year * Presence of mental retardation, dementia, or severe psychotic disorders

Design outcomes

Primary

MeasureTime frameDescription
Brunnstrom Stages of Hemiplegic RecoveryBaseline
Beck Depression InventoryBaselineThe Beck Depression Inventory (BDI) is scored between 0 and 63, where 0 indicates minimal or no depressive symptoms and 63 reflects severe depression; increasing scores correspond to greater severity of depressive symptomatology.
Beck Anxiety InventoryBaselineBeck Anxiety Inventory (BAI) ranges from 0 to 63, with 0 indicating minimal anxiety and 63 indicating severe anxiety; higher scores represent increased severity of anxiety symptoms.
Burden InterviewBaseline
Timed Up and Go TestBaseline
Rivermead Mobility IndexBaselineThe Rivermead Mobility Index (RMI) ranges from 0 to 15. 0 indicates severe dependence with inability to perform basic mobility tasks. 15 indicates full independence in all assessed mobility activities. As the score increases, it reflects a progressive improvement in functional mobility, with greater independence in activities such as transfers, walking, and balance.

Contacts

CONTACTSeda Nur Kemer, PhD
sedanur.kemer@omu.edu.tr+903623121919

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026